The Global Apheresis Equipment Market is driven by
rising prevalence of chronic diseases

The global apheresis equipment market comprises of products
and systems that are majorly utilized for removing undesirable components from
the blood of donors or patients. Apheresis equipment finds widespread usage for
removing platelets, plasma, leukocytes, donor stem cells, and other blood
components. The equipment aids in the separation of whole blood into various
components like plasma, white blood cells, platelets, and red blood cells. Key
advantages offered by apheresis equipment include efficient separation of blood
components with minimal wastage, reduction in side effects for donors, and
ability to collect high quantities of platelets in a single donation. Rising
prevalence of chronic diseases has increased the demand for apheresis
procedures significantly which in turn is propelling the need for efficient and
technologically advanced apheresis equipment.



Apheresis Equipment Market is estimated
to be valued at USD 4.76 Bn in 2025 and is expected to reach USD 10.01 Bn in
2032, exhibiting a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032.

Key Takeaways



Asahi Kasei Medical Co., Ltd., Terumo Corporation, Inc., Fenwal, Inc.,
Haemonetics Corp., Therakos, Inc., B. Braun Melsungen AG, HemaCare Corporation,
Haemonetics Corporation, Cerus Corporation, Kawasumi Laboratories, Miltenyi
Biotec, NxStage Medical, and Kaneka Medix Corporation



Growing prevalence of hematologic cancers, cardiovascular diseases, and
autoimmune disorders is fueling the demand for plasmapheresis and leukapheresis
procedures globally. According to WHO, cardiovascular diseases account for over
17 million deaths annually worldwide.



Major players are expanding their geographical presence across high potential
markets especially Asia Pacific and Middle East & Africa. For instance,
Haemonetics opened a new manufacturing plant in Malaysia in 2022 to support the
demand from Southeast Asian countries.



Market Drivers



Increasing incidence of hematologic malignancies is a major factor augmenting
the Apheresis
Equipment Market Growth. Chemotherapy treatments for the management of
blood cancers often require frequent platelet transfusions which is increasing
the demand for plateletpheresis procedures.

Get More
Insight On -
Apheresis
Equipment Market Growth

Get this Report
in Japanese Language  -  アフェレシス機器市場

Get this Report
in Korean Language  -  아페리시스 장비 시장